In the present study, we compared commonly used, whole blood cardiac marker
POCT assays to an automated central laboratory cTnT assay on first-draw specimens, using the recommended cutoff of the 99th percentile of the reference range and the criteria for AMI proposed in the new universal classification.
The original Cardiac Marker
Guideline Uptake in Europe (CARMAGUE) study (1) surveyed laboratory practice against the then current clinical practice recommendations (2).
Fiomi, which is based in Uppsala, Sweden, is at an advanced stage in developing a panel of point-of-care cardiac marker
assays based on technology that was originally developed by Amic AB.
AegisPOC allows users to connect with any manufacturer's critical care or POC testing device including blood gases, glucose, coagulation, cardiac marker
devices and more.
Roche Diagnostics (Basel, Switzerland) and Response Biomedical (Vancouver, Canada) announced that Response Biomedical has been granted a nonexclusive license under patent rights of Roche Diagnostics to commercialize NT-proBNP (N-terminal prohormone brain natriuretic peptide), a key cardiac marker
for a broad array of cardiovascular conditions.
This TriMark Publications report describes the specific market segment of the in vitro diagnostics (IVD) market devoted to cardiac marker
testing, including size; growth; industry trends; product development and investment; and clinical measurement devices, reagents and supplies.
imaging is an effective, less expensive, and simple technique that helps a physician to decide whether the patient needs an invasive or complicated procedure.
The CARdiac MArker
Guideline Uptake in Europe study (CARMAGUE) was a pilot study to provide baseline data and validate a web-based audit tool to assess compliance of cardiac marker
testing in current clinical practice.
Examples are blood gas tests performed using handheld analyzers at the hospital bedside, whole blood glucose and pregnancy self-testing, rapid infectious disease tests performed in the physician's office or emergency department, and cardiac marker
tests performed in the chest pain clinic.
com/research/3prf9w/cardiac_marker) has announced the addition of the "Global Cardiac Marker
Diagnostic Testing Market Report" report to their offering.
Two Liquid QC Cardiac Marker
Controls--designed for use on Abbott, Bayer, Beckman Coulter, Dade Behring, Intregra, Roche, and TOSOH equipment--includes analytes CK-MB, myoglobin, troponin I, Troponin T, hsCRP, Digoxin, and hCG.
The most accurate way of monitoring heart health is through cardiac marker